IGALMI Trademark

Trademark Overview

On Wednesday, June 26, 2024, a trademark application was filed for IGALMI with the United States Patent and Trademark Office. The USPTO has given the IGALMI trademark a serial number of 98620766. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Wednesday, June 26, 2024. This trademark is owned by BioXcel Therapeutics, Inc.. The IGALMI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals for the treatment of agitation, namely, an orally-dissolving formulation used for the treatment of agitation associated with alcohol withdrawal, opioid use disorder, opioid withdrawal, substance abuse withdrawal, or other central nervous system disorders, namely, dementia and depression
igalmi

General Information

Serial Number98620766
Word MarkIGALMI
Filing DateWednesday, June 26, 2024
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateWednesday, June 26, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPharmaceuticals for the treatment of agitation, namely, an orally-dissolving formulation used for the treatment of agitation associated with alcohol withdrawal, opioid use disorder, opioid withdrawal, substance abuse withdrawal, or other central nervous system disorders, namely, dementia and depression

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, June 26, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBioXcel Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew Haven, CT 06511

Trademark Events

Event DateEvent Description
Wednesday, June 26, 2024NEW APPLICATION ENTERED
Wednesday, June 26, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Related Keywords

igalmi withdrawal treatment namely opioid agitation central other nervous system depression